Eli Lilly Stock Slumps on Lowered Sales Forecast - Yahoo Finance

13 hours ago · Eli Lilly shares tumbled Tuesday after the drugmaker lowered its revenue forecast for the 2024 fiscal year. The maker of weight-loss drugs Mounjaro and Zepbound said sales …

6%
OFF

Eli Lilly Stock Tumbles After New Forecasts Show Weight-loss Drug …

2 weeks from now

13 hours ago · Eli Lilly shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations.Lilly …

yahoo.com

8%
OFF

Eli Lilly Misses Drug Sales Forecast, Shares Drop Over 8%

2 weeks from now

18 hours ago · Eli Lilly’s shares dropped over 8% on lower-than-expected drug sales forecasts. Analysts had projected $7.43 billion in combined sales for Zepbound and Mounjaro; Lilly …

nasdaq.com

7%
OFF

Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight

2 weeks from now

Shares of Eli Lilly & Co. dropped over 7% on Tuesday morning, reaching levels last seen in late November and marking the stock’s worst day since March 15, 2021. The decline followed a ...

msn.com

1%
OFF

S&P 500 Gains And Losses Today: Eli Lilly Stock Falls As Sales …

2 weeks from now

11 hours ago · The S&P 500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's consumer price report.

investopedia.com

8%
OFF

Lilly Shares On Track For Worst Day Since 2021 After ... - Yahoo Finance

2 weeks from now

19 hours ago · (Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time …

yahoo.com

20%
OFF

Eli Lilly Stock Tumbles On Lowered Guidance As Weight-Loss Drug …

2 weeks from now

17 hours ago · Eli Lilly stock fell on lowered Q4 guidance amid slower-than-expected sales for its Zepbound and Mounjaro weight loss drugs. ... Sales climbed 20% to $11.44 billion but lagged …

investors.com

44%
OFF

Are Eli Lilly's Lowered Expectations A Reason To Sell?

2 weeks from now

Oct 31, 2024 · Despite falling on Wednesday, Eli Lilly stock is up by about 44% in 2024 as I write this. Expectations are high with the stock trading for about 63 times the midpoint of …

nasdaq.com

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

16 hours ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

8%
OFF

Lilly Forecasts Weak Sales Of Weight-loss Drug, Shares Slump

2 weeks from now

15 hours ago · STORY: Shares of Eli Lilly tumbled as much as 8% on Tuesday, after the company forecast weaker-than-expected fourth-quarter sales of its weight-loss drug Zepbound.The …

yahoo.com

45%
OFF

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 ... - Yahoo …

2 weeks from now

18 hours ago · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. ...

yahoo.com

5%
OFF

Why Eli Lilly (LLY) Stock Is Declining Today - Yahoo Finance

2 weeks from now

18 hours ago · The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it …

yahoo.com

FAQs about Eli Lilly Stock Slumps on Lowered Sales Forecast - Yahoo Finance Coupon?

Why are Eli Lilly shares falling?

Eli Lilly shares climbed 32% last year but have slumped more than 16% since October after the company reported third quarter sales of the two drugs below Wall Street’s expectations, prompting concerns about moderating demand. ...

Why did Eli Lilly stock tumble Tuesday?

Eli Lilly shares tumbled Tuesday after the drugmaker lowered its revenue forecast for the 2024 fiscal year. The maker of weight-loss drugs Mounjaro and Zepbound said sales grew slower than expected in the fourth quarter. CEO David Ricks said the company expects to produce 60% more doses of the drugs in the first half of 2025 compared to last year. ...

Will Eli Lilly stock remain under a microscope on Wednesday?

Eli Lilly shares could remain under the microscope on Wednesday after falling sharply Tuesday as the pharmaceutical giant lowered its 2024 full-year revenue forecast. This tepid outlook adds to concerns about moderating demand for its flagship weigh-loss drugs. ...

How much will Eli Lilly make In fiscal 2025?

The drugmaker said it anticipates revenue between $58 billion to $61 billion in fiscal 2025, while analysts currently project $59.33 billion. Eli Lilly made the adjustment ahead of Ricks presenting at a healthcare conference Tuesday afternoon. ...

How did Lilly perform in 2023?

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023. Lilly previously provided a range of $13.9 billion to $14.5 billion. The company also provided full-year 2024 guidance of $45 billion, or 32% more than 2023. ...

How much will Eli Lilly's fourth-quarter revenue be?

Eli Lilly said it expects fourth-quarter revenue of roughly $13.5 billion, which would bring full-year revenue to $45 billion, lower than the $45.4 billion to $46 billion range the company projected in its third-quarter report. ...